These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 3913889

  • 1. Topical use of ceftazidime in gram negative pulmonary pathologies.
    Barberis S, Cristaldi G, Galietti F, Giorgis GE, Massaglia GM.
    Panminerva Med; 1985; 27(4):189-94. PubMed ID: 3913889
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with ceftazidime in the management of a variety of gram-negative infections.
    Spantideas A.
    Chemioterapia; 1987 Jun; 6(2 Suppl):377-8. PubMed ID: 3334580
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Mezlocillin in the treatment of acute bronchopneumopathies caused by gram-negative organisms].
    Cioffi R, Cristiano P, Paradisi F.
    Arch Monaldi; 1980 Jun; 35(5-6):291-300. PubMed ID: 6212038
    [No Abstract] [Full Text] [Related]

  • 5. Use of ceftazidime in the treatment of severe localized and systemic infections.
    Gabrielli GB, Corrocher R, De Sandre G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):167-9. PubMed ID: 6370875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical study of 42 patients treated with ceftazidime].
    Farci G, Laconi R, Lai ME, Balestrieri A.
    Clin Ter; 1985 Nov 15; 115(3):169-72. PubMed ID: 3910330
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ceftazidime in febrile SLE patients.
    Boey ML, Feng PH.
    Singapore Med J; 1988 Aug 15; 29(4):393-5. PubMed ID: 3074518
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of peritoneal infection in continuous ambulatory peritoneal dialysis with ceftazidime].
    Ryckelynck JP, Hurault de Ligny B, Vergnaud M, Dapogny C, Batho JM, Landru I.
    Therapie; 1987 Aug 15; 42(1):37-9. PubMed ID: 3296299
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ceftazidime in the treatment of severe bacterial infections].
    Maresová V, Cizmárová L, Havlík J, Stafová J, Vacek V, Gabrielová A, Neubertová K.
    Sb Lek; 1988 Nov 15; 90(11-12):339-43. PubMed ID: 3064274
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
    Lodise TP, Nau R, Kinzig M, Drusano GL, Jones RN, Sörgel F.
    J Antimicrob Chemother; 2007 Nov 15; 60(5):1038-44. PubMed ID: 17785282
    [Abstract] [Full Text] [Related]

  • 16. Metronidazole in pulmonary anaerobic infection.
    Nigam P, Kapoor KK, Gupta RK, Gupta AK, Goyal BM.
    J Assoc Physicians India; 1983 Dec 15; 31(12):779-81. PubMed ID: 6370951
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical experience in the treatment of bacterial bronchopneumopathy with cefotaxime].
    Montanari S, Roca A, Pasqua F, Gramiccioni E.
    Clin Ter; 1983 Apr 30; 105(2):119-24. PubMed ID: 6305552
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.